The evolving role of bisphosphonates

被引：18

作者：

Theriault, RL ^{[1
]}

Hortobagyi, GN ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 03期

关键词：

D O I：

10.1053/sonc.2001.23494

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：284 / 290

页数：7

共 50 条

[1] ADAMI S, 1993, OSTEOPOROSIS INT, V3, pS21
[2] THE ABDOMINAL VISCERAL INNERVATION AND THE EMETIC REFLEX - PATHWAYS, PHARMACOLOGY, AND PLASTICITY
ANDREWS, PLR
DAVIS, CJ
BINGHAM, S
DAVIDSON, HIM
HAWTHORN, J
MASKELL, L
[J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (02) : 325 - 345
[3] ALENDRONATE DISTRIBUTED ON BONE SURFACES INHIBITS OSTEOCLASTIC BONE-RESORPTION IN-VITRO AND IN EXPERIMENTAL HYPERCALCEMIA MODELS
AZUMA, Y
SATO, H
OUE, Y
OKABE, K
OHTA, T
TSUCHIMOTO, M
KIYOKI, M
[J]. BONE, 1995, 16 (02) : 235 - 245
[4] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
Berenson, JR
Lichtenstein, A
Porter, L
Dimopoulos, MA
Bordoni, R
George, S
Lipton, A
Keller, A
Ballester, O
Kovacs, MJ
Blacklock, HA
Bell, R
Simeone, J
Reitsma, DJ
Heffernan, M
Seaman, J
Knight, RD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 488 - 493
[5] Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events
Berenson, JR
Lichtenstein, A
Porter, L
Dimopoulos, MA
Bordoni, R
George, S
Lipton, A
Keller, A
Ballester, O
Kovacs, M
Blacklock, H
Bell, R
Simeone, JF
Reitsma, DJ
Heffernan, M
Seaman, J
Knight, RD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 593 - 602
[6] UPTAKE BY BONE OF PYROPHOSPHATE, DIPHOSPHONATES AND THEIR TECHNETIUM DERIVATIVES
BISAZ, S
JUNG, A
FLEISCH, H
[J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 54 (03): : 265 - 272
[7] Body JJ, 1997, CANCER, V80, P1699, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1699::AID-CNCR23>3.3.CO
[8] 2-A
[9] Boissier S, 1997, CANCER RES, V57, P3890
[10] NEUROPHARMACOLOGY OF CHEMOTHERAPY-INDUCED EMESIS
BORISON, HL
MCCARTHY, LE
[J]. DRUGS, 1983, 25 : 8 - 17

← 1 2 3 4 5 →